Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques

Abstract

The effect of androgen receptor transcriptional activation by RU58841, a nonsteroidal anti-androgen, was studied in the human prostate cancer PC3 cell line by cotransfection with wild-type androgen receptor (wt AR) and an androgen-responsive reporter (MMTV-ARE-CAT) construct. Anti-androgens, hydroxyflutamide, and Casodex, and the antiestrogen, genistein, were studied in parallel for comparison with RU58841. The wt AR was activated only by the androgen dihydrotestosterone (DHT). Neither the anti-androgens nor antiestrogen can enhance AR transcriptional activity at 10−11-10−7 M in PC3 cells. Hydroxyflutamide, RU58841, and Casodex, but not genistein, displayed competitively suppressive effects on DHT activation of wt AR. The potency of RU58841 was comparable to that of hydroxyflutamide. From this result, topical application of RU58841, which is considered to be a potential therapy for skin diseases, may induce systemic side effects. However, RU58841, on topical application, revealed a potent increase in density, thickening, and length of hair in the macaque model of androgenetic alopecia, whereas no systemic effects were detected. Together our results suggest that RU58841 may have potent antagonism to the wt AR and could be considered as a topically applied active anti-androgen for the treatment of androgen-dependent skin disorders, such as acne, androgenetic alopecia, and hirsutism.

References

  1. 1.

    Neumann, F. and Topert, M. (1986). J. Steroid Biochem. 25, 885–895.

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Raynaud, J.-P. and Ojasoo, T. (1986). J. Steroid Biochem. 25, 811–833.

    Article  CAS  PubMed  Google Scholar 

  3. 3.

    Walkeling, A. E. (1992). Cancer Surveys 14, 71–85.

    Google Scholar 

  4. 4.

    Beato, M. (1989). Cell 56, 335–344.

    Article  CAS  PubMed  Google Scholar 

  5. 5.

    Carson-Jurica, M. A., Schrader, W. T., and O’Malley, B. W. (1990). Endocr. Rev. 11, 201–220.

    CAS  PubMed  Google Scholar 

  6. 6.

    Moguilewsky, M. and Bouton, M. M. (1988). J. Steroid Biochem. 31, 699–710.

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    Neri, R. and Kassem, N. (1987). In: Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Furr, B. J. A. and Wakeling, A. E. (eds.). Bailliere Tindall, London, pp. 160–169.

    Google Scholar 

  8. 8.

    Moguilewsky, M., Bertagna, C., and Hucher, M. (1987). J. Steroid Biochem. 27, 871–875.

    Article  CAS  PubMed  Google Scholar 

  9. 9.

    Moguilewsky, M., Cotard, M., Proulx, L., Tournemine, C., and Raynaud, J. P. (1987). In: Prostate Cancer, Part A: Research, Endocrine Treatment, and Histopathology Progress in Clinical and Biological Research, vol. 243A. Murphy, G., Khoury, S., Kuss, R., Chatelain, C., and Denis, L. (eds.). Alan Liss, New York, 243A, pp. 315–340.

    Google Scholar 

  10. 10.

    Harris, M. G., Coleman, S. G., Faulds, D., and Chrisp, P. (1993). Drugs Aging 3, 9–25.

    CAS  PubMed  Google Scholar 

  11. 11.

    Furr, B. J. A., Curry, V. B., Woodburn, J. R., Chesterson, R., and Tucker, H. (1987). J. Endocr. 113(3), R7-R9.

    CAS  PubMed  Google Scholar 

  12. 12.

    Teutsch, G., Goubet, F., Battmann, T., Bonfils, A., Bouchoux, F., Cerede, E., et al. (1994). J. Steroid Biochem. Mol. Biol. 48, 111–119.

    Article  CAS  PubMed  Google Scholar 

  13. 13.

    Battmann, T., Bonfils, C., Branche, C., Humbert, J., Goubet, F., Teutsch, G., et al. (1994). J. Steroid Biochem. Mol. Biol. 48, 55–60.

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    Martin, P. M., Horwitz, K. B., Ryan, D. S., and McGuire, W. L. (1978). Endocrinology 103, 1860–1867.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Makela, S., Davis, V., Tally, W. C., Korkman, J., Salo, L., Vihko, R., et al. (1994). Environ. Health Perspect. 102, 572–578.

    CAS  PubMed  Google Scholar 

  16. 16.

    Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S. (1994). Nutr. Cancer 21, 113–131.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Lutsky, B. N., Budak, M., Kozio, P., Monahan, M., and Neri, R. O. (1975). J. Invest. Dermatol. 64, 412–417.

    Article  CAS  PubMed  Google Scholar 

  18. 18.

    Uno, H. (1987). In: Models in Dermatology 3. Maibach, H. I., and Lowe, N. J. (eds.). S. Karger AG, Basel, pp. 159–169.

    Google Scholar 

  19. 19.

    Uno, H. (1986). In: Seminars in Reproductive Endocrinology: Andrology in Woman, 4, Speroff, L. (ed.). Thieme-Stratton, New York, pp. 131–141.

    Google Scholar 

  20. 20.

    Berrevoets, C. A., Veldscholte, J., and Mulder, E. (1993). J. Steroid Biochem. Mol. Biol. 46, 731–736.

    Article  CAS  PubMed  Google Scholar 

  21. 21.

    Yeh, S., Miyamoto, H., and Chang, C. (1997). Lancet 349, 852.

    Article  CAS  PubMed  Google Scholar 

  22. 22.

    Katzenellenbogen, J. A., O’Malley, B. W., and Katzenellenbogen, B. S. (1996). Mol. Endocrinolo. 10, 119–131.

    Article  CAS  Google Scholar 

  23. 23.

    Ayub, M. and Levell, M. J. (1989). J. Steroid. Biochem. 33, 251–255.

    Article  CAS  PubMed  Google Scholar 

  24. 24.

    Furr, B. J. A. (1989). Horm. Res. 32, 69–76.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Brouwer, B. D., Tetelin, C., Leroy, T., Bonfils, A., and Neste, D. V. (1997). Br. J. Dermatol. 137, 699–702.

    Article  PubMed  Google Scholar 

  26. 26.

    Gomez, E. C. and Frost, P. H. (1975). In: Animal Models in Dermatology—Relevance to Human Dermatopharmacology and Dermatotoxicology. Maibach, H. (ed.). Churchill Livingstone, Edinburgh, pp. 190–202.

    Google Scholar 

  27. 27.

    Obana, N., Chang, C., and Uno, H. (1997). Endocrinology 138, 356–361.

    Article  CAS  PubMed  Google Scholar 

  28. 28.

    Chang, C., Kokontis, J., and Liao, S. (1988). Science 240, 324–326.

    Article  CAS  PubMed  Google Scholar 

  29. 29.

    Berns, E. M. J., De Boer, W., and Mulder, E. (1986). Prostate 9, 247–259.

    Article  CAS  PubMed  Google Scholar 

  30. 30.

    Nielsen, D. A., Chang, T.-C., and Shapiro, D. J. (1989). Anal. Biochem. 179(1), 19–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr. Chawnshang Chang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pan, HJ., Wilding, G., Uno, H. et al. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques. Endocr 9, 39–43 (1998). https://doi.org/10.1385/ENDO:9:1:39

Download citation

Key Words

  • Hydroxyflutamide
  • Casodex
  • alopecia
  • prostate